新药杂质评估02-Evaluating Impurities in Drugs 02.docVIP

Evaluating Impurities in Drugs (Part II of III) In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities. Mar 2, 2012By: Kashyap R. Wadekar,?Mitali Bhalme,?S. Srinivasa Rao,?K. Vigneshwar Reddy,?L. Sampath Kumar,?E. BalasubrahmanyamPharmaceutical TechnologyVolume 36, Issue 3, pp. 58-72  The public and the pharmaceutical industry are placing greater attention on impurities in drug as evidenced by the attention given to pharmaceutical impurities in books, journal articles, and national and international